| Dr Michelle Ann Garcia Silsby, PHARMD | |
|
14501 Hindry Ave, Hawthorne, CA 90250-6748 | |
| (310) 727-0402 | |
| (310) 727-0409 |
| Full Name | Dr Michelle Ann Garcia Silsby |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 14501 Hindry Ave, Hawthorne, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477866051 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RPH51480 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michelle Ann Garcia Silsby, PHARMD 14501 Hindry Ave, Hawhorne, CA 90250 Ph: (310) 727-0402 | Dr Michelle Ann Garcia Silsby, PHARMD 14501 Hindry Ave, Hawthorne, CA 90250-6748 Ph: (310) 727-0402 |
News Archive
H. Lundbeck A/S (Lundbeck) and Merck, known outside the United States and Canada as MSD, today announced a commercialization agreement for SYCREST (asenapine) sublingual tablets (5 mg, 10 mg). Under the terms of the agreement, Lundbeck will pay an undisclosed fee as well as product supply payments in exchange for exclusive commercial rights to SYCREST in all markets outside the United States, China and Japan. Lundbeck expects to launch SYCREST in the European Union (EU), where it is already approved, at the beginning of 2011.
The University of Miami Miller School of Medicine's Department of Otolaryngology-Head and Neck Surgery is one of eight otolaryngology training programs in the U.S. to receive the Ruth L. Kirschstein National Research Service Award Institutional Research Training Grant (T32) for interdisciplinary research training in otolaryngology.
Advanced Accelerator Applications (AAA), a fast growing international player in Molecular Nuclear Medicine (MNM), announced today that they have received orphan drug designation status for their radiopharmaceutical, Gallium-68 DOTATATE.
Researchers at the DZNE (Germany), at Massachusetts General Hospital (USA) and at the genomic medicine company Sangamo Therapeutics, Inc. tested a novel gene regulation approach to treat brain diseases such as Alzheimer's in laboratory studies.
› Verified 4 days ago
Manoj Gandhy, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5055 W El Segundo Blvd, Hawthorne, CA 90250 Phone: 310-679-1166 Fax: 310-679-6361 | |
Raisa Angelica Nerosa, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13921 Kornblum Ave Unit 18, Hawthorne, CA 90250 Phone: 310-951-7059 | |
Lena Yang, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 14501 Hindry Ave, Hawthorne, CA 90250 Phone: 310-727-0402 | |
Jose Luis Diaz Jr., PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 14250 Prairie Ave, Hawthorne, CA 90250 Phone: 310-978-9167 | |
Sherryl Apo, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4775 W Rosecrans Ave, Hawthorne, CA 90250 Phone: 310-263-7330 | |
Talin Dishchekenian, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11831 Hawthorne Blvd, Hawthorne, CA 90250 Phone: 310-679-3668 | |
Ms. Huynh Wat, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2700 W 120th St, Hawthorne, CA 90250 Phone: 323-492-1001 Fax: 323-492-1011 |